768 related articles for article (PubMed ID: 18069390)
21. AIDS-related non-Hodgkin's lymphoma in the first decade of highly active antiretroviral therapy.
Palmieri C; Treibel T; Large O; Bower M
QJM; 2006 Dec; 99(12):811-26. PubMed ID: 17085516
[TBL] [Abstract][Full Text] [Related]
22. The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma.
Bower M; Weir J; Francis N; Newsom-Davis T; Powles S; Crook T; Boffito M; Gazzard B; Nelson M
AIDS; 2009 Aug; 23(13):1701-6. PubMed ID: 19550283
[TBL] [Abstract][Full Text] [Related]
23. Gene therapy strategies for AIDS-related malignancies.
Curiel TJ; Piché A; Kasono K; Curiel DT
Gene Ther; 1997 Dec; 4(12):1284-8. PubMed ID: 9472551
[TBL] [Abstract][Full Text] [Related]
24. AIDS-associated malignancies.
Akanmu AS
Afr J Med Med Sci; 2006 Dec; 35 Suppl():57-70. PubMed ID: 18050776
[TBL] [Abstract][Full Text] [Related]
25. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
[TBL] [Abstract][Full Text] [Related]
26. Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: incidence, presentation, treatment, and survival.
Diamond C; Taylor TH; Aboumrad T; Anton-Culver H
Cancer; 2006 Jan; 106(1):128-35. PubMed ID: 16329140
[TBL] [Abstract][Full Text] [Related]
27. [Non Hodgkin's and Hodgkin's lymphomas and HIV: frequency, outcome and immune response under HAART; Clermont-Ferrand University Hospital, 1991-2003].
Jacomet C; Lesens O; Villemagne B; Darcha C; Tournilhac O; Henquell C; Cormerais L; Gourdon F; Peigue-Lafeuille H; Travade P; Beytout J; Laurichesse H
Med Mal Infect; 2006 Mar; 36(3):157-62. PubMed ID: 16503104
[TBL] [Abstract][Full Text] [Related]
28. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults.
International Collaboration on HIV and Cancer
J Natl Cancer Inst; 2000 Nov; 92(22):1823-30. PubMed ID: 11078759
[TBL] [Abstract][Full Text] [Related]
29. Pulmonary manifestations of acquired immunodeficiency syndrome-associated malignancies.
Irwin DH; Kaplan LD
Semin Respir Infect; 1993 Jun; 8(2):139-48. PubMed ID: 8278681
[TBL] [Abstract][Full Text] [Related]
30. [Systemic HIV-non-Hodgkin lymphoma in the era of HAART. Natural history].
Juzbasic S; Spina M; Vaccher E; Tirelli U
Recenti Prog Med; 2001 Nov; 92(11):676-89. PubMed ID: 11765662
[TBL] [Abstract][Full Text] [Related]
31. Modern management of non-Hodgkin lymphoma in HIV-infected patients.
Mounier N; Spina M; Gisselbrecht C
Br J Haematol; 2007 Mar; 136(5):685-98. PubMed ID: 17229246
[TBL] [Abstract][Full Text] [Related]
32. AIDS defining lymphomas in the era of highly active antiretroviral therapy (HAART): an African perspective.
Sissolak G; Abayomi EA; Jacobs P
Transfus Apher Sci; 2007 Aug; 37(1):63-70. PubMed ID: 17931978
[TBL] [Abstract][Full Text] [Related]
33. Assessing the impact of HAART on the incidence of defining and non-defining AIDS cancers among patients with HIV/AIDS: a systematic review.
Cobucci RN; Lima PH; de Souza PC; Costa VV; Cornetta Mda C; Fernandes JV; Gonçalves AK
J Infect Public Health; 2015; 8(1):1-10. PubMed ID: 25294086
[TBL] [Abstract][Full Text] [Related]
34. Impact of HAART on HIV-linked malignancies.
Laurence J
AIDS Read; 2003 May; 13(5):202, 205. PubMed ID: 12800820
[No Abstract] [Full Text] [Related]
35. Non-AIDS-defining cancers: should antiretroviral therapy be initiated earlier?
Cinti SK; Gandhi T; Riddell J
AIDS Read; 2008 Jan; 18(1):18-20, 26-32. PubMed ID: 18240449
[TBL] [Abstract][Full Text] [Related]
36. Profile of patients with Kaposi's sarcoma in the era of highly active antiretroviral therapy.
Gallafent JH; Buskin SE; De Turk PB; Aboulafia DM
J Clin Oncol; 2005 Feb; 23(6):1253-60. PubMed ID: 15718323
[TBL] [Abstract][Full Text] [Related]
37. AIDS and associated malignancies.
Wood C; Harrington W
Cell Res; 2005; 15(11-12):947-52. PubMed ID: 16354573
[TBL] [Abstract][Full Text] [Related]
38. Risk of cancers during interrupted antiretroviral therapy in the SMART study.
Silverberg MJ; Neuhaus J; Bower M; Gey D; Hatzakis A; Henry K; Hidalgo J; Lourtau L; Neaton JD; Tambussi G; Abrams DI
AIDS; 2007 Sep; 21(14):1957-63. PubMed ID: 17721103
[TBL] [Abstract][Full Text] [Related]
39. AIDS-associated malignancies.
Krown SE
Cancer Chemother Biol Response Modif; 1996; 16():441-61. PubMed ID: 8639393
[TBL] [Abstract][Full Text] [Related]
40. Ten years later: a single hospital experience with malignancy in HIV/AIDS.
Reed M; Cosgrove JM; Cindrich R; Parithivel VS; Gad Y; Bangalore M; Uzor R; Kalim J; Segura R; Albu E
J Surg Oncol; 2010 Sep; 102(3):282-6. PubMed ID: 20740588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]